Le Lézard
Classified in: Covid-19 virus

Global Medical Plastics Market Report 2021: Future Growth Potential Enhanced by Increasing Healthcare Expenditure in Developing Economies - ResearchAndMarkets.com


The "Global Medical Plastics Market 2021 - Transformative Mega Trends Power the Industry" report has been added to ResearchAndMarkets.com's offering.

Medical plastics offer remarkable benefits over conventional materials, such as metals, glass, and ceramics, and have been revolutionizing the medical industry over the last few years.

They are extremely cost-effective, flexible, durable, biocompatible, chemically inert, resistant to wear and tear, lightweight, and recyclable. Plastic materials offer miniaturization, greater ease of processing and sterilization and are being used worldwide for various medical applications including medical devices, surgical instruments, capital equipment, prosthetics, implants, and pharma packaging.

Both by value and volume, CTP including polyolefins (PO), polyvinyl chloride (PVC), polyethylene terephthalate (PET), and polystyrene (PS) had the highest share in the global medical plastics market in 2020 and are expected to retain it during the forecast period.

These polymers are extensively preferred due to their low costs, performance benefits, and wider availability. CTP are majorly used in packaging, such as manufacturing medical bottles, containers, prefilled syringes, caps and closures, blister packaging, blood bags, and other pharma and medical packaging products.

Developing countries, especially those in Asia-Pacific, MEASA, and Latin America are undergoing rapid economic development and urbanization and have emerged as prominent low-cost manufacturing hubs for various plastic-based medical products. The mature markets of North America and Europe are focused on acquiring sustainable value-added medical plastics while providing improved performance across diverse domains.

Due to the recent COVID-19 pandemic, the healthcare industry witnessed a significant drop in elective and semi-elective medical procedures including plastic, replacement, exploratory, and cardiovascular surgeries in 2020, as hospitals focused on treating COVID-19 patients.

To retain their position in the supply chain and ensure a smooth product supply of products, medical plastic manufacturers are anticipated to strengthen long-term relationships with resin producers, distributors, compounders, and extruders.

In addition, the market is expected to exhibit mergers and acquisitions and vertical integration activities among companies to increase their product offerings and stay ahead of the competition. Companies are also focused on developing value-added and innovative product grades and enhancing the performance of existing ones to drive revenue growth.

Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Analysis, Medical Plastics Market

3. Growth Opportunity Analysis, Commodity Thermoplastics

4. Growth Opportunity Analysis, Engineering Thermoplastics

5. Growth Opportunity Analysis, Other Plastics

6. Growth Opportunity Universe, Medical Plastics Market

7. Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/rbcqn3


These press releases may also interest you

at 07:15
PowerBand Solutions Inc. ("PowerBand", "PBX" or the "Company"), a comprehensive trading and financing technology platform transforming the online experience to sell, trade, lease, and finance vehicles, is pleased to...

at 07:00
Village Farms International, Inc. ("Village Farms" or the "Company") today announced it will host a conference call to discuss its first quarter 2024 financial results on Wednesday, May 8, 2024, at 8:30 a.m. ET. Participants can access the...

at 07:00
Just Right Products Inc., the wholly owned subsidiary of ADM Endeavors ("ADM" or the "Company") , a diversified, direct marketing and value-added manufacturing company, announces that CEO Marc Johnson and CFO Alex Archer will host...

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:15
Carter's, Inc. , the largest branded marketer in North America of apparel exclusively for babies and young children, today reported its first quarter fiscal 2024 results. "We exceeded our sales and earnings objectives in the first quarter," said...

at 06:01
First Quarter Key Metrics Total revenue increased 5% to $4.1 billion, including organic revenue growth of 5%Operating margin decreased 210 basis points to 36.0%, and operating margin, adjusted for certain items, increased 100 basis points to 39.7%EPS...



News published on and distributed by: